GlassScriptPhysician profile
Stacey A Leithliter
NPI 1437208410
$1,523.72
in general payments reported to CMS, 2019-2025
17 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $494 · 2022: $182 · 2023: $420 · 2024: $254 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $613.34 | 2021-2025 | Xtandi, Myrbetriq |
| Endo Pharmaceuticals INC. | $169.04 | 2021-2024 | Aveed, Xiaflex, Edex |
| Teleflex LLC | $108.66 | 2021-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $100.17 | 2023-2025 | Gemtesa |
| 180 Medical, INC. | $77.43 | 2023-2024 | Speedicath, Gentlecath |
| Janssen Biotech, INC. | $71.71 | 2023-2025 | Erleada |
| Urovant Sciences INC | $69.59 | 2021-2022 | |
| Endo USA, INC. | $57.96 | 2024-2025 | Xiaflex, Edex, Aveed |
| Coloplast Corp | $41.89 | 2023-2024 | Speedicath |
| Abbvie INC. | $37.82 | 2021 | |
| Axonics, INC. | $34.59 | 2021-2023 | Axonics |
| Antares Pharma, INC. | $32.24 | 2025 | Xyosted |
| Boston Scientific Corporation | $27.31 | 2021-2025 | Axonics |
| Tolmar, INC. | $22.98 | 2025 | Jatenzo, Eligard |
| Telix Pharmaceuticals | $21.70 | 2023 | Illuccix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $20.41 | 2023 | Hd-View |
| Olympus America INC. | $16.88 | 2023 | Cysto-Nephro Videoscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Leithliter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.